Physician profile
J Michael Tedesco
NPI 1497704787
$2,950.34
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $865 · 2020: $379 · 2021: $752 · 2022: $689 · 2023: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.29 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $756.69 | 2019-2022 | |
| Abbvie INC. | $580.76 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Roche Diagnostics Corporation | $222.20 | 2019-2021 | |
| Therapeuticsmd, INC. | $207.83 | 2019-2022 | |
| Astellas Pharma US INC | $199.56 | 2019-2023 | Myrbetriq, Veozah |
| Pfizer INC. | $169.37 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $128.53 | 2019-2022 | |
| Organon LLC | $92.11 | 2021-2023 | Nexplanon |
| Urovant Sciences INC | $90.97 | 2021-2022 | |
| Exeltis, USA INC. | $81.11 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $75.35 | 2021-2023 | |
| Allergan, INC. | $56.57 | 2019-2020 | |
| Myovant Sciences INC. | $52.40 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $43.65 | 2019 | |
| Evofem Biosciences, INC. | $41.14 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $40.66 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $38.69 | 2019-2020 | |
| Avion Pharmaceuticals | $31.27 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $29.01 | 2023 | Gemtesa |
| Axonics, INC. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Tedesco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.